Siga Technologies (SIGA) EBT Margin Growth (3y) (2013 - 2025)

Siga Technologies (SIGA) EBT Margin Growth (3y) (2013 - 2025) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBT Margin Growth (3y) (Qtr)
1 Haleon 87.22 Bn 85.35 Bn - -
2 Teva Pharmaceutical Industries 39.60 Bn 35.87 Bn 1.97 Bn 1,840.00
3 Zoetis 31.46 Bn 29.52 Bn 1.62 Bn -134.00
4 Takeda Pharmaceutical 26.49 Bn 22.44 Bn 4.39 Bn -5,626.00
5 United Therapeutics 23.03 Bn 20.88 Bn 648.10 Mn -1,686.00
6 Universe Pharmaceuticals 23.03 Bn -10.56 Bn - -
7 Viatris 20.90 Bn 19.09 Bn 1.16 Bn -1,570.00
8 Neurocrine Biosciences 17.50 Bn 16.19 Bn 800.70 Mn 5,487.00
9 Elanco Animal Health 12.33 Bn 11.91 Bn 785.00 Mn -225.00
10 Siga Technologies 225.56 Mn 70.59 Mn - -

Historic Data

Download Data
DateValue
Sep 30, 2025 -37,866.00
Jun 30, 2025 3,912.00
Mar 31, 2025 200.00
Dec 31, 2024 -947.00
Sep 30, 2024 10,092.00
Jun 30, 2024 559.00
Mar 31, 2024 7,369.00
Dec 31, 2023 1,015.00
Sep 30, 2023 -7,612.00
Jun 30, 2023 -12,609.00
Mar 31, 2023 42,816.00
Dec 31, 2022 14,164.00
Sep 30, 2022 7,908.00
Jun 30, 2022 12,874.00
Mar 31, 2022 -3,052.00
Dec 31, 2021 -422,934.00
Sep 30, 2021 -15,919.00
Jun 30, 2021 27,028.00
Mar 31, 2021 64,103.00
Dec 31, 2020 97,178.00